Author

W.-P. Kong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 2 Organism:mouse· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

B. S. Graham· 2 shared K. Bahl· 2 shared A. Carfi· 1 shared A. Peretti· 1 shared A. Schafer· 1 shared A. T. DiPiazza· 1 shared A. West· 1 shared A. Woods· 1 shared

Activity by Year

2020-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. S. Graham

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

An optimized messenger RNA vaccine candidate protects non-human primates from Zika virus infection

B. A. Bollman, N. Nunna, K. Bahl, C. J. Hsiao, H. Bennett, S. Butler, B. Foreman, K. E. Burgomaster, M. Aleshnick, W.-P. Kong, B. E. Fisher, T. J. Ruckward, K. M. Morabito, B. S. Graham, K. A. Dowd, , A. Carfi

This study compares two ZIKV mRNA vaccines, showing that mRNA-1893 provides complete protection at a lower dose than mRNA-1325 in non-human primates.

bioRxiv · Oct 11, 2022 · PreprintImmunology

A Multivalent Polyomavirus Vaccine Elicits Durable Neutralizing Antibody Responses in Macaques

A. Peretti, D. G. Scorpio, W.-P. Kong, Y.-Y. S. Pang, M. P. McCarthy, K. Ren, M. Jackson, B. S. Graham, C. B. Buck, P. M. McTamney, D. V. Pastrana

This study shows a multivalent polyomavirus vaccine induces high, durable neutralizing antibodies in macaques without adverse effects.

bioRxiv · Sep 26, 2022Immunology

SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness

K. S. Corbett, D. Edwards, S. R. Leist, O. M. Abiona, S. Boyoglu-Barnum, R. A. Gillespie, S. Himansu, A. Schafer, C. T. Ziwawo, A. T. DiPiazza, K. H. Dinnon, S. M. Elbashir, C. A. Shaw, A. Woods, E. J. Fritch, , Wang

This paper describes the development of an mRNA vaccine (mRNA-1273) against SARS-CoV-2, showing it induces neutralizing antibodies and CD8 T cell responses and protects mice from infection.

bioRxiv · Jun 11, 2020Immunology